NCT01789060View on ClinicalTrials.gov

p-AKT Expression on Clinical Outcomes in Malignant Lymphoma

CompletedOBSERVATIONAL
Enrollment

262

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Malignant LymphomaP13K-AKT Pathway Deregulation
Interventions
OTHER

p-AKT immunohistochemical staining

p-AKT staining on the adequate paraffin-embedded biopsy specimen or unstained slides

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT01789060 - p-AKT Expression on Clinical Outcomes in Malignant Lymphoma | Biotech Hunter | Biotech Hunter